Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Percent.
The item "Net-Profit-Margin" stands at 27.26 percent as of 09/30/2025, the highest value since 09/30/2024.
As of the end of Johnson & Johnson's third quarter, the item "Net Profit Margin" stands at 27.26 Percent. This represents an increase of 5.23 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.51 percentage points compared to the value the year prior.
The 1 year change in percentage points is 10.51.
The 3 year change in percentage points is 7.31.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Profit Margin | 905,699,262,464.00 |
![]() | AbbVie Inc - Net Profit Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Profit Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Profit Margin | 280,205,508,085.11 |
![]() | Novartis AG - Net Profit Margin | 255,096,620,580.91 |